Figure 2From: Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort studyStratified Analysis GSTT1 genotype and treatment arm for DFS (2a, b) and OS (2c, d). a) Arm: CAF; Endpoint: DFS. b) Arm: CAF+HDC; Endpoint DFS. c) Arm: CAF; Endpoint: OS. d) Arm: CAF+HDC; Endpoint: OS.Back to article page